Chemed Corporation (CHE) Misses Q3 EPS by 9c; reiterates guidance

Chemed Corporation (NYSE: CHE) reported Q3 EPS of $5.27, $0.09 worse than the analyst estimate of $5.36. Revenue for the quarter came in at $624.9 million versus the consensus estimate of $626.04 million.

GUIDANCE:

Chemed Corporation sees FY2025 EPS of $22.30, versus the consensus of $22.15.

For earnings history and earnings-related data on Chemed Corporation (CHE) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• Jefferies says Europe battery electric vehicle sales jump in May
• Schwab's May activity shows margin loans nearly double